{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "PDR001",
        "type": {
          "id": "2a4c86f7-65cd-41d1-a89f-1fd8ab461915",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "b4585ca8-6766-4c37-94fe-67566a6bf860",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Anti-PD-1 antibody",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Dabrafenib",
        "type": {
          "id": "ced98cfe-b8f1-4655-8949-4e1e1d5b4812",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "72a5b090-848b-4635-80ce-89a3480c77ef",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "BRAF inhibitor",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Trametinib",
        "type": {
          "id": "3448b864-56ac-4193-b54f-bb929cd15f8a",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "c5717310-5702-443a-b87c-cdf969ca5c66",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "MEK inhibitor",
        "productIds": [
          "prod_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Placebo",
        "type": {
          "id": "721f9156-6ea8-4138-bf83-61462eeaf475",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "9534fee2-7293-412a-851c-2c66f9fb2b4c",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo for PDR001"
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "598dff08-2bce-4c52-a268-b5d60b0fe6be",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0a0af7d6-6b07-4011-a8f2-4259e7678c0a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Used for management of immune-related adverse events (irAEs) and pyrexia"
      },
      {
        "id": "int_6",
        "name": "RANK-ligand inhibitors",
        "type": {
          "id": "390993d0-afa5-4cbe-b55e-4381e9f6dd4e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "c7eda01d-0c9e-44a6-ac82-fb6528993378",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted bone targeted therapies (e.g., denosumab)"
      },
      {
        "id": "int_7",
        "name": "Bisphosphonates",
        "type": {
          "id": "c72ff5a2-534c-48f8-b736-a360fa0e9fb2",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "f3f08473-afd6-4800-88cf-ca9d04b55bb4",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted concomitant agents"
      },
      {
        "id": "int_8",
        "name": "CYP2C or CYP3A4 substrates",
        "type": {
          "id": "42f51aab-adb3-45f2-9b79-a5c93e74527b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "3c352487-8a1b-4e3e-a8e1-bf9ea9ef60f0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Require caution when co-administered with dabrafenib due to drug-drug interactions"
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "PDR001",
        "administrableDoseForm": {
          "id": "9ce492a3-ebde-4ddd-9c72-f20836b35428",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "41230cec-ab35-4970-aaec-9bfb46264157",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "a4929dbb-cedd-486e-a923-562a5e68fe73",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Novartis"
      },
      {
        "id": "prod_2",
        "name": "Dabrafenib",
        "administrableDoseForm": {
          "id": "da6f4889-fed9-4487-9ab8-a55fae6950fa",
          "code": "C17998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Unknown",
          "standardCode": {
            "id": "9576cac4-71b5-4424-93c5-066286e09e83",
            "code": "C17998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Unknown",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "c450e028-d85a-4550-aa68-49740dc02930",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Novartis"
      },
      {
        "id": "prod_3",
        "name": "Trametinib",
        "administrableDoseForm": {
          "id": "fea59765-c736-4f3f-8383-b5d05ffbba6d",
          "code": "C17998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Unknown",
          "standardCode": {
            "id": "a7016854-813f-4368-97e9-73e3388c56ef",
            "code": "C17998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Unknown",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "9d35865f-ff9d-4ff6-9b2f-ef60864e2541",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Novartis"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Standard Triplet Regimen",
        "instanceType": "Administration",
        "dose": "PDR001 400 mg, Dabrafenib 150 mg, Trametinib 2 mg",
        "doseFrequency": "PDR001 Q4W, Dabrafenib BID, Trametinib QD",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_2",
        "name": "Safety Run-in Co-administration",
        "instanceType": "Administration",
        "dose": "Dabrafenib 150 mg, Trametinib 2 mg",
        "doseFrequency": "90 minutes after PDR001 completion",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Part 1 specific instruction"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "PDR001",
        "instanceType": "Substance",
        "description": "Anti-PD-1 monoclonal antibody"
      },
      {
        "id": "sub_2",
        "name": "Dabrafenib",
        "instanceType": "Substance",
        "description": "BRAF inhibitor"
      },
      {
        "id": "sub_3",
        "name": "Trametinib",
        "instanceType": "Substance",
        "description": "MEK inhibitor"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 8,
      "productCount": 3,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "PDR001",
        "role": "Investigational Product",
        "description": "Anti-PD-1 antibody"
      },
      {
        "name": "Dabrafenib",
        "role": "Investigational Product",
        "description": "BRAF inhibitor"
      },
      {
        "name": "Trametinib",
        "role": "Investigational Product",
        "description": "MEK inhibitor"
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo for PDR001"
      },
      {
        "name": "Corticosteroids",
        "role": "Concomitant Medication",
        "description": "Used for management of immune-related adverse events (irAEs) and pyrexia"
      },
      {
        "name": "RANK-ligand inhibitors",
        "role": "Concomitant Medication",
        "description": "Permitted bone targeted therapies (e.g., denosumab)"
      },
      {
        "name": "Bisphosphonates",
        "role": "Concomitant Medication",
        "description": "Permitted concomitant agents"
      },
      {
        "name": "CYP2C or CYP3A4 substrates",
        "role": "Concomitant Medication",
        "description": "Require caution when co-administered with dabrafenib due to drug-drug interactions"
      }
    ],
    "products": [
      {
        "name": "PDR001",
        "doseForm": "Powder for solution for infusion",
        "strength": "Not specified",
        "manufacturer": "Novartis"
      },
      {
        "name": "Dabrafenib",
        "doseForm": "Not specified",
        "strength": "Not specified",
        "manufacturer": "Novartis"
      },
      {
        "name": "Trametinib",
        "doseForm": "Not specified",
        "strength": "Not specified",
        "manufacturer": "Novartis"
      }
    ],
    "substances": [
      {
        "name": "PDR001",
        "description": "Anti-PD-1 monoclonal antibody"
      },
      {
        "name": "Dabrafenib",
        "description": "BRAF inhibitor"
      },
      {
        "name": "Trametinib",
        "description": "MEK inhibitor"
      }
    ],
    "administrations": [
      {
        "name": "Standard Triplet Regimen",
        "dose": "PDR001 400 mg, Dabrafenib 150 mg, Trametinib 2 mg",
        "frequency": "PDR001 Q4W, Dabrafenib BID, Trametinib QD",
        "route": "PDR001 IV, Dabrafenib Oral, Trametinib Oral",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Safety Run-in Co-administration",
        "dose": "Dabrafenib 150 mg, Trametinib 2 mg",
        "frequency": "90 minutes after PDR001 completion",
        "route": "Oral",
        "duration": "Part 1 specific instruction"
      }
    ],
    "devices": []
  }
}